keyboard_arrow_up

Gastrointestinal Partnering Market Terms and Agreements

eportsnReports.com adds report Gastrointestinal Partnering Market Terms and Agreements to its store.The Gastrointestinal Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gastrointestinal partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter gastrointestinal partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors gastrointestinal technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

" Delivery of this report will take 1-3 days after purchase.”

Purchase Report Directly @ http://www.reportsnreports.com/Purchase.aspx?name=279487

This report contains over 1,000 links to online copies of actual gastrointestinal deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of gastrointestinal dealmaking and business activities. Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in gastrointestinal dealmaking since 2009 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.

Single User License US $1995

Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=279487

Chapter 3 provides a review of the leading gastrointestinal deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of gastrointestinal deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides comprehensive access to all gastrointestinal deals since 2009 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all gastrointestinal partnering deals signed and announced since 2009. The chapter is organized by specific gastrointestinal therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all gastrointestinal partnering deals signed and announced since 2009. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in gastrointestinal partnering and dealmaking since 2009.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of gastrointestinal technologies and products.

Benefits

Gastrointestinal Partnering Terms and Agreements provides the reader with the following key benefits:

  • In-depth understanding of gastrointestinal deal trends since 2009
  • Access gastrointestinal deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between gastrointestinal partner companies
  • Comprehensive access to over 1,000 links to actual gastrointestinal deals entered into by the world’s biopharma companies
  • Indepth review of gastrointestinal deals entered into by the leading fifty bigpharma companies
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner gastrointestinal opportunities
  • Uncover companies actively partnering gastrointestinal opportunities

About Us:
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. Not limited to the Pharmaceuticals Market ReportsnReports.com offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, medical devices, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.